Education and Training
MD - Emory University School of Medicine, Atlanta, GA
Pediatrics - Emory University School of Medicine, Atlanta, GA
Pediatric Hematology/Oncology - Children's Hospital of Philadelphia, Philadelphia PA
Pediatric Hematology-Oncology – American Board of PediatricsPediatrics – American Board of Pediatrics
Titles and Academic Titles
Instructor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Departments and Services
Inhibitors in hemophilia
Gene therapy for blood disorders
Doshi BS, Rogers RS, Whitworth HB, Stabnick EA, Britton J, Butler RB, Obstfeld A, and Witmer CM: Utility of Repeat Testing in the Evaluation for von Willebrand Disease in Pediatric Patients. Journal of Thrombosis and Haemostasis 00: 1-10, Aug 2019 Notes: doi.org/10.1111/jth.14591.
Zielonka B, Cohen AR, Smith-Whitley K, Doshi BS. : Iliopsoas hematoma in a patient with sickle cell disease. Pediatr Blood Cancer. Mar 12 2018 Notes: doi: 10.1002/pbc.27040. [Epub ahead of print]
Doshi BS, Abramowsky C, Briones M, Bunting ST.: Concomitant a novel ALAS2 mutation and GATA1 mutation in a newborn: a case report and review of the literature. American Journal of Blood Research 4(1): 41-5, 2014. PMCID: PMC4165116
Doshi BS, Gangadharan B, Doering CB, Meeks SL.: Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody-specific inhibition. PloS One 7(10): e48172, 2012. PMCID: PMC3483154
Meeks SL, Cox CL, Healey JF, Parker ET, Doshi BS, Gangadharan B, Barrow RT, Lollar P: A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function. Blood 120(12): 2512-20, Sep 2012. PMCID: PMC3448263
Wax A, Doshi BS, Arulselvan A, Obstfeld A, Lambert MP.: Comparison of LTA Versus WBILA in Pediatric Patients with Suspected Platelet Function Disorders. Blood 132: 3762, Dec 2018.
Bhoj V, Li L, Samelson-Jones BJ, Doshi BS, Ellebrecht C, Payne A, Arruda VR, Milone MC.: Optimized FVIII-Domain-Based Chimeric Antigen Receptors to Specifically Target FVIII Inhibitor-Producing B Cells in Hemophilia A. Blood 132: 2196, Dec 2018 Notes: doi.org/10.1182/blood-2018-99-120031.
Doshi BS, Felner EI: Stimulation and Suppression Testing. Endocrine Pathophysiology. Felner, E and Umpierrez, G. (eds.). Lippincott Williams & Wilkins, Page: 406-425, 2014.
Posters and Presentations
Doshi BS, Lambert MP, Raffini LJ, Arruda VR, George LA: Anti-CD20 and sirolimus for refractory inhibitors in hemophilia A. Research Practice in Thrombosis and Haemostasis 1(Suppl. 1): 665, 2017 Notes: Poster Presentation at ISTH World Congress July 2017, Berlin.
Doshi BS, Lacey SF, Chen F, Raffini LJ, Arruda VR.: Novel correlation between B cell survival cytokines and inhibitors in hemophilia A. Blood 130(Suppl 1): 3677, 2017 Notes: Poster Presentation at ASH Annual Meeting, December 2017, Atlanta GA.
Paessler M, Obstfeld A, Doshi B, Lambert M: A case report of catastrophic thrombosis, acquired sitosterolemia and hereditary xerocytosis in a 2 year-old girl after tumor resection. International Journal of Laboratory Hematology 39 (Suppl 2): 90, Jun 2017 Notes: Presentation at ISLH Annual Meeting 2017.
Doshi BS. "BAFF in hemophilia A with inhibitors." HTRS/NASTH Scientific Symposium. New Orleans, LA. May 2019.
Doshi BS. "Utility of Repeat Testing in the Evaluation for von Willebrand Disease in Pediatric Patients." 61st American Society of Hematology Annual Meeting. San Diego, CA. Dec 2018.
Doshi BS. "The UnBLyS-ful State: Blocking Factor VIII Inhibitors with BLyS Depletion." 61st American Society of Hematology Annual Meeting. San Diego, CA. Dec 2018.
Doshi BS. "Novel Biomarkers of Inhibitors in Hemophilia A," Mid-Atlantic Region III HTCs Annual Meeting, Alexandria, VA, USA. April 2018.
Doshi BS. "Novel Correlation between B Cell Survival Cytokines and Inhibitors in Hemophilia A", 46th Annual Philadelphia Workshop on Hemostasis, Thrombosis and Atherosclerosis, Philadelphia, PA, USA. November 2017.
Awards and Honors
2017, Abstract Achievement Award, American Society of Hematology 59th Annual Meeting
2011, Junior Inductee, Alpha Omega Alpha Medical Honor Society, Emory School of Medicine
2011, Abstract Achievement Award, American Society of Hematology
2008, Darrell R. Stokes Award for Excellence in Biology, Department of Biology, Emory University College of Arts and Sciences
2007, Inductee, Phi Beta Kappa National Honor Society, Emory University College of Arts and Sciences
Editorial and Academic Positions
2018-present, Pediatric Blood and Cancer, ad-hoc peer reviewer
2018-present, Revista Brasileira de Hematologia e Hemoterapia, ad-hoc peer-reviewer
2017-present, PLoS One, ad-hoc peer-reviewer
Leadership and Memberships
Memberships in Professional Organizations
2017-present, International Society on Thrombosis and Haemostasis
2016-present, Hemostasis and Thrombosis Research Society
2016-present, American Society of Pediatric Hematology/Oncology
2016-present, American Society of Hematology
2011-present, Alpha Omega Alpha
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.